$GRDN

2 stories mentioning GRDNUpdated 47d ago

Every FINWIRES story that references GRDN, newest first.

Guardian Pharmacy's Site Tour Reinforces Confidence in Prospects, BofA Says

Guardian Pharmacy Services' (GRDN) pharmacy site tour reinforces confidence in the company's long-term market share gains, BofA Securities said in a note Wednesday."We come away from the tour incrementally positive that Guardian has the right employees, culture, and strategy to continue to grow its market share over the next decade," the report said.BofA analysts increased their target multiple to reflect incrementalconfidence on longer-term share gains. BofA kept its buy rating while raising its price target to $47 from $42.Price: $43.08, Change: $+0.66, Percent Change: +1.56%

$GRDN

Wire88d ago

Oppenheimer Adjusts Price Target on Guardian Pharmacy Services to $43 From $38, Maintains Outperform Rating

Guardian Pharmacy Services (GRDN) has an average rating of buy and mean price target of $42.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $33.55, Change: $-2.98, Percent Change: -8.16%

$GRDN

Track with the FINWIRES app suite

FolioX

Track GRDN in your portfolio

WheelAI

Analyze GRDN options with the wheel strategy

StockInsider

See market sentiment on GRDN